Invitae Corp. (NVTA)

18.02
0.03 0.17
NYSE : Health Services
Prev Close 17.99
Open 17.76
Day Low/High 17.05 / 18.30
52 Wk Low/High 9.04 / 28.75
Volume 2.24M
Avg Volume 2.23M
Exchange NYSE
Shares Outstanding 95.18M
Market Cap 1.77B
EPS -1.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

A Weak Bounce Continues as Stock Picking Heats Up

A Weak Bounce Continues as Stock Picking Heats Up

The market action is creating some mis-pricing in individual stocks. But if the market stays under pressure then stock picking will remain difficult.

Swinging for the Small-Cap Biotech Fences Requires Accepting Strikeouts

Swinging for the Small-Cap Biotech Fences Requires Accepting Strikeouts

Striking out is painful, but is not as impactful as missing out on the next potential home run because you're still brooding about whiffing on your last investment.

IBM and Netflix Go Separate Ways in Nervous Trading

IBM and Netflix Go Separate Ways in Nervous Trading

I don't expect to see the bears and shorts press too hard right now but there isn't going to be much upside momentum.

These Intriguing ETFs Are on the Cutting Edge of Disruptive Technologies

These Intriguing ETFs Are on the Cutting Edge of Disruptive Technologies

Ark Invest has developed a series of specialized exchange-traded funds that own shares in companies involved in 'disruptive innovation.'

Electric Car Stocks Get a Charge as Pockets of Momentum Develop

Electric Car Stocks Get a Charge as Pockets of Momentum Develop

When the indices aren't offering much opportunity money flows into individual speculative names.

3 Small Biotechs to Watch as Earnings Season Winds Down

3 Small Biotechs to Watch as Earnings Season Winds Down

One already is up nicely on its results, while the other two should issue reports of interest in the next few days.

Here Are 3 Small-Cap Names for Biotech Investors to Consider

Here Are 3 Small-Cap Names for Biotech Investors to Consider

We look at a slightly riskier part of the sector...that should be able to reach profitability with little to no additional funding needs.

Consider These Diagnostic Testing Firms

Consider These Diagnostic Testing Firms

Diagnostic firms can have an advantage of recurring revenue streams.

Names to Watch Amid Biotech's Nascent Rally

Names to Watch Amid Biotech's Nascent Rally

Progenics and Tesaro are among sagging small-cap biotech stocks that could rebound in coming months.

3 Small Biotechs Turn on the Revenue Jets

3 Small Biotechs Turn on the Revenue Jets

BioDelivery Sciences, Neos Therapeutics and Invitae Corp. are delivering big increases in sales.

3 of My Favorite Medical Diagnostic Plays

3 of My Favorite Medical Diagnostic Plays

These equities have been in rally mode since April.

3 Favorite Biotech Stocks for the Second Quarter

3 Favorite Biotech Stocks for the Second Quarter

Your questions are answered in our latest addition of the biotech mailbag.

Lackluster Market on Tons of Earnings

Some good discussions today on the Daily Diary. Look forward to continuing the conversation tomorrow as we look to wrap up a solid week for equities. Market was lackluster today but had a ton of earnings reports to take into account. Not to mention ...

Shark Bites: Traders Could Trip on This Market Bounce

Shark Bites: Traders Could Trip on This Market Bounce

V-shaped moves are more common than they used to be.

Three Health-Care Growth Plays

Three Health-Care Growth Plays

Eagle Pharmaceuticals, Invitae and Celgene should do well this year and are attractively priced.

Invitae Inviting as Undervalued Growth Play

Invitae Inviting as Undervalued Growth Play

The rapidly growing genetic testing concern is executing its growth plan marvelously.

Biotech, Health Care Likely to Drive IPOs at NYSE in Second Half

Biotech, Health Care Likely to Drive IPOs at NYSE in Second Half

Garvis Toler, head of global capital markets at the NYSE, reviews the landscape of IPOs during the first half of 2015 and previews what's in store for the second half.